ArticleScientific reports2025
Change in platelet and leukocyte counts and hospital mortality in adults with acute kidney injury receiving continuous renal replacement therapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hematological parameter dynamics in critically ill patients treated with oXirisBMC nephrology · 2026Observational
- Persistent Severe Acute Kidney Injury Among Critically Ill Patients: Outcomes and Predictive Markers-A Single-Center Retrospective Cohort Study.Critical care research and practice · 2026Article
- The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock.Annals of intensive care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundChanges in platelet and white blood cell (WBC) counts during CRRT could identify patients at risk for adverse outcomes. We examined the association of change in platelet and WBC from pre-CRRT to during-CRRT with hospital mortality.
methodsThis multicenter, retrospective cohort study included 1,413 adults with AKI requiring CRRT at two tertiary medical centers (2011-2021). Platelet and WBC change from pre- to during CRRT were assessed as a percentage and categorized by standard deviation (SD). Multivariable LASSO regression and interaction analyses investigated associations with hospital mortality.
resultsA > 1 SD platelet count drop during CRRT was independently associated with hospital mortality (aOR: 1.82, 95% CI: 1.06, 3.13). A > 1 SD WBC count increase during CRRT did not significantly increase mortality (aOR 1.41, 95% CI: 0.88, 2.29). Interaction analyses revealed four sub-groups associated with increased mortality: pre-CRRT low platelet count that remained low, pre-CRRT normal platelet count that decreased, pre-CRRT elevated WBC count that remained high, and normal or elevated pre-CRRT WBC count that increased.
interpretationIn critically ill adults, a drop in platelets after CRRT initiation was associated with increased hospital mortality. Monitoring platelet and WBC during CRRT in reference to pre-CRRT levels could help identify high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.